High capacity for leukotriene biosynthesis in peripheral blood during pregnancy

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 4, 2013, Pages 245-255

  Schaible, A M ^a   Koeberle, A ^a   Northoff, H ^b   Lawrenz, B ^b   Weinigel, C ^c   Barz, D ^c   Werz, O ^a   Pergola, C ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Inflammation; Leukotrienes; Lipoxygenase; Pregnancy

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL METABOLISM; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; LEUKOCYTE COUNT; MATERNAL BLOOD; MONOCYTE; NEUTROPHIL COUNT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

12(S)-HYDROXY-5-CIS-8,10-TRANS-HEPTADECATRIENOIC ACID; 12-HHT; 5(S)-HYDRO(PERO)XY-6-TRANS-8,11,14-CIS-EICOSATETRAENOIC ACID; 5-H(P)ETE; 5-LIPOXYGENASE; 5-LO; AA; ARACHIDONIC ACID; COX; CYCLOOXYGENASE; EDTA; ELECTROSPRAY IONIZATION; ESI; ETHYLENEDIAMINETETRAACETATE; FMLP; FORMYL-METHIONYL-LEUCYL-PHENYLALANINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; INFLAMMATION; LEUKOTRIENE; LEUKOTRIENE RECEPTOR ANTAGONIST; LEUKOTRIENES; LIPOPOLYSACCHARIDE; LIPOXYGENASE; LPS; LT; LTRA; PBMC; PBS; PBS PLUS 1MG/ML GLUCOSE; PBS PLUS 1MG/ML GLUCOSE PLUS 1MM CACL(2); PERIPHERAL BLOOD MONONUCLEAR CELLS; PG BUFFER; PGC BUFFER; PHOSPHATE BUFFERED SALINE; PMNL; POLYMORPHONUCLEAR LEUKOCYTES; PREGNANCY; REACTIVE OXYGEN SPECIES; ROS; SDS-PAGE; SEM; SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS; STANDARD ERROR OF THE MEAN; ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; UPLC-MS/MS;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; BLOOD CELL COUNT; FEMALE; GRANULOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENES; PREGNANCY; YOUNG ADULT;

EID: 84884534656     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.06.004     Document Type: Article

References (52)

1. Veenstra van Nieuwenhoven A.L., Heineman M.J., Faas M.M. The immunology of successful pregnancy. Hum. Reprod. Update 2003, 9:347-357.
2. Buyon J.P. The effects of pregnancy on autoimmune diseases. J. Leukoc. Biol. 1998, 63:281-287.
3. Sacks G.P., Studena K., Sargent K., Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 1998, 179:80-86.
4. Crouch S.P., Crocker I.P., Fletcher J. The effect of pregnancy on polymorphonuclear leukocyte function. J. Immunol. 1995, 155:5436-5443.
5. Minagawa M., Narita J., Tada T., Maruyama S., Shimizu T., Bannai M., Oya H., Hatakeyama K., Abo T. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell. Immunol. 1999, 196:1-13.
6. Luppi P., Haluszczak C., Betters D., Richard C.A., Trucco M., DeLoia J.A. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol. 2002, 72:874-884.
7. Krause P.J., Ingardia C.J., Pontius L.T., Malech H.L., LoBello T.M., Maderazo E.G. Host defense during pregnancy: neutrophil chemotaxis and adherence. Am. J. Obstet. Gynecol. 1987, 157:274-280.
8. Kindzelskii A.L., Huang J.B., Chaiworapongsa T., Fahmy R.M., Kim Y.M., Romero R., Petty H.R. Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils. J. Clin. Invest. 2002, 110:1801-1811.
9. Peters-Golden M., Henderson W.R. Leukotrienes. N. Engl. J. Med. 2007, 357:1841-1854.
10. Di Gennaro A., Haeggstrom J.Z. The leukotrienes: immune-modulating lipid mediators of disease. Adv. Immunol. 2012, 116:51-92.
11. Rådmark O., Werz O., Steinhilber D., Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 2007, 32:332-341.
12. Surette M.E., Palmantier R., Gosselin J., Borgeat P. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J. Exp. Med. 1993, 178:1347-1355.
13. Rey E., Boulet L.P. Asthma in pregnancy. BMJ 2007, 334:582-585.
14. Mihrshahi S., Belousova E., Marks G.B., Peat J.K. T. Childhood asthma prevention, pregnancy and birth outcomes in families with asthma. J. Asthma 2003, 40:181-187.
15. Schatz M., Dombrowski M.P. Clinical practice. Asthma in pregnancy. N. Engl. J. Med. 2009, 360:1862-1869.
16. Ellegard E.K. The etiology and management of pregnancy rhinitis. Am. J. Respir. Med. 2003, 2:469-475.
17. Soares E.M., Mason K.L., Rogers L.M., Serezani C.H., Faccioli L.H., Aronoff D.M. Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent streptococcus pyogenes. J. Immunol. 2013, 190:1614-1622.
18. Crocker I., Lawson N., Daniels I., Baker P., Fletcher J. Significance of fatty acids in pregnancy-induced immunosuppression. Clin. Diagn. Lab. Immunol. 1999, 6:587-593.
19. Imai T., Arai T. [Quantitative changes in leukotriene B4 release in neutrophilic leukocytes activated by Ca ionophore during pregnancy-normal pregnancy and preeclampsia]. Nihon Sanka Fujinka Gakkai Zasshi 1996, 48:405-411.
20. Jian F., Ma Y., Liu Z., Wang L., Zhang Y. The change of LTB4 and 5-LO during pregnancy. Arch. Gynecol. Obstet. 2013, in press.
21. Pergola C., Dodt G., Rossi A., Neunhoeffer E., Lawrenz B., Northoff H., Samuelsson B., Rådmark O., Sautebin L., Werz O. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:19881-19886.
22. Pergola C., Rogge A., Dodt G., Northoff H., Weinigel C., Barz D., Radmark O., Sautebin L., Werz O. Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes. FASEB J. 2011, 25:3377-3387.
23. Fischer L., Szellas D., Radmark O., Steinhilber D., Werz O. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors. FASEB J. 2003, 17:949-951.
24. Werz O., Burkert E., Samuelsson B., Rådmark O., Steinhilber D. Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. Blood 2002, 99:1044-1052.
25. O'Leary P., Boyne P., Flett P., Beilby J., James I. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin. Chem. 1991, 37:667-672.
26. Luppi P., Haluszczak C., Trucco M., Deloia J.A. Normal pregnancy is associated with peripheral leukocyte activation. Am. J. Reprod. Immunol. 2002, 47:72-81.
27. Werz O. 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets Inflamm. Allergy 2002, 1:23-44.
28. Carlin A., Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract. Res. Clin. Obstet. Gynaecol. 2008, 22:801-823.
29. Saeed S.A., Mitchell M.D. Formation of arachidonate lipoxygenase metabolites by human fetal membranes, uterine decidua vera and placenta. Prostaglandins Leukot. Med. 1982, 8:635-640.
30. Mitchell M.D., Grzyboski C.F. Arachidonic acid metabolism by lipoxygenase pathways in intrauterine tissues of women at term of pregnancy. Prostaglandins Leukot. Med. 1987, 28:303-312.
31. Brown N.L., Slater D.M., Alvi S.A., Elder M.G., Sullivan M.H., Bennett P.R. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term. Mol. Hum. Reprod. 1999, 5:668-674.
32. Durn J.H., Marshall K.M., Farrar D., O'Donovan P., Scally A.J., Woodward D.F., Nicolaou A. Lipidomic analysis reveals prostanoid profiles in human term pregnant myometrium. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:21-26.
33. Bennett P.R., Elder M.G., Myatt L. The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987, 33:837-844.
34. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63:601-610.
35. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010, 63:425-433.
36. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
37. Nancy P., Tagliani E., Tay C.S., Asp P., Levy D.E., Erlebacher A. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 2012, 336:1317-1321.
38. Sheikh S., Parhar R.S., Bakheet R., Saleh S., Collison K., Al-Mohanna F. Immobilization of rolling NK cells on platelet-borne P-selectin under flow by proinflammatory stimuli, interleukin-12, and leukotriene B4. J. Leukoc. Biol. 2004, 76:603-608.
39. Tager A.M., Bromley S.K., Medoff B.D., Islam S.A., Bercury S.D., Friedrich E.B., Carafone A.D., Gerszten R.E., Luster A.D. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 2003, 4:982-990.
40. Bäck M., Dahlen S.E., Drazen J.M., Evans J.F., Serhan C.N., Shimizu T., Yokomizo T., Rovati G.E. International union of basic and clinical pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol. Rev. 2011, 63:539-584.
41. Kindzelskii A.L., Ueki T., Michibata H., Chaiworapongsa T., Romero R., Petty H.R. 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase form a supramolecular complex in human neutrophils that undergoes retrograde trafficking during pregnancy. J. Immunol. 2004, 172:6373-6381.
42. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003, 21:3352-3357.
43. Carrillo C., Del Mar Cavia M., Roelofs H., Wanten G., Alonso-Torre S.R. Activation of human neutrophils by oleic acid involves the production of reactive oxygen species and a rise in cytosolic calcium concentration: a comparison with N-6 polyunsaturated fatty acids. Cell. Physiol. Biochem. 2011, 28:329-338.
44. Miller C., Russell A.S. Polymorphonuclear leukocyte response to stimulation in vitro during pregnancy. Inflammation 1986, 10:215-222.
45. Osorio Y., Bonilla D.L., Peniche A.G., Melby P.C., Travi B.L. Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production. J. Leukoc. Biol. 2008, 83:1413-1422.
46. Hughes G.C., Clark E.A., Wong A.H. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses. J. Leukoc. Biol. 2013, 93:369-375.
47. von Dadelszen P., Watson R.W., Noorwali F., Marshall J.C., Parodo J., Farine D., Lye S.J., Ritchie J.W., Rotstein O.D. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am. J. Obstet. Gynecol. 1999, 181:408-414.
48. Mayer K., Fegbeutel C., Hattar K., Sibelius U., Kramer H.J., Heuer K.U., Temmesfeld-Wollbruck B., Gokorsch S., Grimminger F., Seeger W. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003, 29:1472-1481.
49. Wesche D.E., Lomas-Neira J.L., Perl M., Chung C.S., Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol. 2005, 78:325-337.
50. Naccasha N., Gervasi M.T., Chaiworapongsa T., Berman S., Yoon B.H., Maymon E., Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am. J. Obstet. Gynecol. 2001, 185:1118-1123.
51. Bakhireva L.N., Jones K.L., Schatz M., Klonoff-Cohen H.S., Johnson D., Slymen D.J., Chambers C.D. G. Organization of Teratology Information Specialists Collaborative Research, Safety of leukotriene receptor antagonists in pregnancy. J. Allergy. Clin. Immunol. 2007, 119:618-625.
52. Sarkar M., Koren G., Kalra S., Ying A., Smorlesi C., De Santis M., Diav-Citrin O., Avgil M., Lavigne S.V., Berkovich M., Einarson A. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur. J. Clin. Pharmacol. 2009, 65:1259-1264.